Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 294
Selected: 0
NCT IDTitle
NCT06412497MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
NCT02161783Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
NCT02525029Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
NCT06295757Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
NCT00357565Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
NCT03687073Trial of Indole-3-Carbinol and Silibinin
NCT00303667Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT05705700Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
NCT07153016LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer
NCT01173016Administration of IV Laronidase Post Bone Marrow Transplant in Hurler
NCT00855114Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
NCT05322408HCW9218 in Select Advanced Solid Tumors
NCT02179359Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
NCT00602446Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT04426669A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
NCT04105270RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
NCT05643014Observational Study of Exposure to Environmental Toxicants Among Firefighters
NCT00005985Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
NCT00369291CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT02765997StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies
NCT01962636Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
NCT04555811FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL
NCT07541573GTB-5550 in Advanced Solid Tumors
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT04225572Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)
NCT01171469Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
NCT04630769FT516 and IL2 With Enoblituzumab for Ovarian Cancer
NCT00638820Reduced Intensity AlloTransplant For Osteopetrosis
NCT00274846Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
NCT00392782Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NCT01705288Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
NCT05308316Sugars in Cigarettes
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT00618696Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
NCT00258427Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
NCT02666105Exemestane in Post-Menopausal Women With NSCLC
NCT05502302App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer
NCT00619021Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
NCT02361047Let's Play! Healthy Kids After Cancer
NCT03365661QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
NCT04363346Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
NCT00818649Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT07493538MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
NCT02670837Study of Cellutome System for Treatment of Individual Lesions in EB Pts
NCT00005998Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00617188Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer